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Staurosporine (STU) is a microbial alkaloid which is an universal kinase inhibitor. In order to un-
derstand its mechanism of action it is important to explore its structure-properties relationships. In
this paper we provide the results of a computational study of the structure, the chiroptical proper-
ties, the conformational flexibility of STU as well as the correlation between the electronic circular
dichroism (ECD) spectra and the structure of its complex with anaplastic lymphoma kinase.
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1. Introduction
Staurosporine (STU) is a microbial alkaloid which
is a universal kinase inhibitor that has a strong cy-
totoxic effect on cancer cells [1] and also exhibits
antimicrobial, hypotensive activity against yeast and
fungi. Moreover, it causes platelet aggregation, in-
hibition of smooth muscle contraction, and activa-
tion of macrophages [2, 3]. STU and its analogues
are widespread in nature. The title compound was
first isolated from actinomycete Streptomyces stau-
rosporeus in 1977 [4] but it also occurs in cyanobac-
teria and marine invertebrates, including sponges,
tunicates, and mollusks [3, 5]. STU belongs to the
indolocarbazole family of compounds which is pre-
sented in the living organisms only in form of its
indolo(2,3-a)carbazoles [6] isomers. STU is a deriva-
tive of indolo(2,3-a)pyrrole(3,4-c)carbazole [2, 7]. The
biosynthesis of the indolocarbazole ring in STU in-
volves two tryptophan molecules, the sugar moiety
from glucose, and methionine [8]. The products of sev-
eral genes participate in the biosynthetic process [3].
The chemical structure of STU (Fig. 1) can be divided
into two units:
i) an aminodesoxy sugar which adopts the boat con-
formation in the solid state, and is linked to the agly-
cone through a pair of C–N bonds and
ii) a planar indolocarbazole heterocycle [9].
STU was also chemically synthesized [8] and the
structure of STU and its absolute configuration (2′S,
3′R 4′R, 6′R) were determined using X-ray crystal-
lography [10]. Anti-tumour properties of STU have
extensively been reported in scientific literature over
the past few decades [7, 11, 12]. STU is a highly po-
tent and non-specific inhibitor of various forms of
kinases [13], and to date about 337 three dimen-
sional X-ray crystal structures of STU and its ana-
logues exist in the RCSB protein data bank (PDB)
(www.rcsb.org) [14]. The crystal structures reveal that
STU binds with high affinity to adenosine triphos-
phate (ATP) binding sites which are usually located
between nitrogen and carbon terminal domains of ki-
nases. The indolo(2,3-a)carbazole moiety tends to oc-
cupy the hydrophobic adenine-binding pocket while
the lactamate group might form hydrogen bonds to the
backbone of the hinge segment [3]. The sugar moi-
ety tends to adopt a boat-shaped conformation in the
solid state and might participate in hydrophobic inter-
actions as well as in hydrogen bonds within the ri-
bose binding site (Fig. 2) [15]. The high number of
hydrogen bonds between the methylamino nitrogen of
the glycosidic ring with surrounding residues might
also contribute to the binding affinity [3]. Thus STU
exhibits binding affinity towards a broad spectrum of
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various kinases, and therefore the title compound it-
self would not be successful as an anti-cancer drug
itself because it would also interfere with other non-
pathological cellular processes [16]. In order to solve
the issue of broad specificity of STU, various forms
of STU analogues have been designed (e. g. UNC-
01, UNC-02, K25a, and rebeccamycine) which exhibit
high level of selectivity against various kinases [9].
Interactions between the STU and the kinases induce
structural changes which can be explored by a vari-
ety of experimental and computational methods. Elec-
tronic circular dichroism (ECD) is a fast and sensitive
method for exploring changes in the secondary struc-
ture (far UV) and in the tertiary structure (near UV)
of proteins and protein-ligand complexes [17, 18]. Ex-
perimental ECD curves can be compared to calculated
ECD spectra and important insight at the atomic level
can be gained [19, 20].
In this paper we present the results of a compu-
tational study of the structure, the flexibility, and
the electronic circular dichroism of STU followed by
a model study of the effect of STU binding [21] on
the ECD spectra of an important STU target, anaplastic
lymphoma kinase (ALK) [22].
2. Methods
The structure of STU was taken from the ALK-
STU complex available from the protein data bank
(PDB) (PDB ID 3LCS.PDB) [15]. The hydrogen
atoms were added using GaussView5.0 [23] and the
molecule’s geometry was optimized at the density
functional theory (DFT) level [24, 25] with the
Table 1. Geometric parameters of STU in the solid state, the optimized values obtained at the B3LYP/6-31+G(d) level in gas
phase, the B3LYP/6-31+G(d)-optimized structural parameters in presence of solvent using PCM model, and the averaged one
from 100 ns MD simulation.
STU chemical structure PDB structure STU PDB STU STU MD averaged
numbering structure in gas in solvent structure
Dihedral angles
4b, 3′, 2′, 4′N4 O6, C22, C21, N4 90 −30.36 −30.23 121
4′N4, 4′, 5′, 13 N4, C23, C24, N3 −160.28 −136.8 −136.31 −141.63
4′, 5′, 6′, 1′ C23, C24, C25, O4 5.35 −8.74 −8.69 9.14
(4′ NH C28), (4′ N4), 6′, 13 C28, N4, C25, N3 −138.22 126.28 127.45 −132.67
(3′ O6 C27), (3′ O6), 12, 11a C27, O6, N2, C17 −13.03 −11.52 −10.24 8.89
Angles
5′, 4′, 3′ C24, C23, C22 106.1 108.23 108.31 106.45
2′, 1′, 6′ C21, O4, C25 118.25 121.13 121.07 120.42
H-Bond
(3′ O6), (4′ N4) O6, N4 3.09 2.94 2.94 2.79
(4′N4), (4′ N4,H43), (3′ O6) N4, H43, O6 89 99.5 100.8 74.61
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Fig. 1 (colour online). Chemical structure of Staur-
sporine [10]. STU (R1 = R2 = H) 1 UCN-01 (R1 = OH, R2
= H) 5 UCN-02 (R1 = H, R2 = OHO6).
B3LYP functional and 6-31+G(d) [26 – 29] basis set.
Calculations were performed both in the gas phase
and with the polarisable continuum model presenting
a hydrophobic environment (dielectric constant 4.0).
Subsequently time-dependent density functional
(TD-DFT) calculations were carried out for the first
20 singlet states using the same functional and the
same basis set. All electronic structure calculations
were done using the Gaussian09 code [30]. The ECD
spectra were visualized using GaussView5.0. Molec-
ular dynamics simulations were carried out using
Gromacs 4.5.3 code [31]. The force field parameters
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Table 2. Conversion between atomic names numbers of STU
according the chemical nomenclature and protein data bank
(PDB).
Atom type Chemical structure PDB structure
O5 5, O5 1
C8 5 2
N1 6 3
H12 6, H12 4
C9 7 5
H9 7, R1, R2 6
C10 7a 7
C7 4c 8
C6 4b 9
C5 4a 10
C4 4 11
H41 4, H41 12
C3 3 13
H3 3, H3 14
C2 2 15
H2 2, H2 16
C1 1 17
H11 1, H11 18
C20 13a 19
N3 13 20
C19 12b 21
C18 12a 22
C11 7b 23
C12 7c 25
C13 8 25
H13 8, H13 26
C14 9 27
H14 9, H14 28
C15 10 29
H15 10, H15 30
C16 11 31
H16 11, H16 32
C17 11a 33
N2 12 34
C21 2′ 35
C26 2′ C26 36
O4 1′ 37
C25 6′ 38
C24 5′ 39
C23 4′ 40
N4 4′ N4 41
H42 4′ N4, H42 42
H43 4′ N4, H43 43
C28 4′ NH, C28 44
C22 3′ 45
O6 3′ O6 46
C27 3′ O6, C27 47
were calculated using the PRODRG online server
(http://davapc1.bioch.dundee.ac.uk/cgi-bin/prodrg)[32].
The structure was optimized in the gas phase, then
solvated using a box with single point charge (SPC)
water molecules [33], and finally minimized again.
Subsequently a productive molecular dynamics (MD)
Fig. 2 (colour online). Structure of the complex of anaplas-
tic lymphoma kinase complex with STU (prepared from sol-
vated structure 3LCS.pdb and visualized using VMD [22]).
simulation was run for 10 ns in isothermal-isobaric
(NPT) ensemble at 310 K applying the Berendsen ther-
mostat. Protein circular dichroism calculations were
carried out using the semiempirical matrix method [34]
as implemented on the DICHROCALC server [35]
(http://comp.chem.nottingham.ac.uk/dichrocalc/) using
the ab initio derived monopoles [36, 37]. The calcula-
tions were done as follows:
i) using the crystal structures of the free anaplas-
tic lymphoma kinase (3L9P.PDB), the protein parts
from the ALK-STU complex (3LCS.PDB), and
ALK-adenosine diphosphate (ALK-ADP) complex
(3LCT.PDB) and
ii) using the averaged structures of the protein parts
from the 100 ns MD simulations of the free enzyme
and the ALK-STU and ALK-ADP complexes [38].
The visualization of the ALK-STU complex was
done using the visual molecular dynamics (VMD) pro-
gram [22].
3. Results and Discussion
Some geometric parameters of potentially more
flexible parts of the STU molecule, derived from the
quantum-chemically optimized coordinates and crys-
tal structures of STU are presented in Table 1. The
structures optimized in the gas phase and those ob-
tained with the solvent model look very similar. More
significant differences were found between the min-
imized structures and the structure in the solid state
used as starting points of our geometry optimizations.
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Table 3. Distances and dihedral angles between the tryptophan chromophores in the solid state and the free ALK and ALK-
Staurosporine complex. The distances are measured between the CD2 atoms from two residues and the dihedral angles
between the CD1 and CD3 atoms from the first residue and the CD3 and CD1 atoms from the second residue. The atom
names are according PDB nomenclature.
TRP Residues ALK Distance ALK Dihedral angle ALK-STU Distance ALK-STU Dihedral angle
(Crystal Structure) (Crystal Structure) (Crystal Structure) (Crystal Structure)
1295-1320 9.89 37.17 9.85 36.52
1295-1366 11.08 46.67 11.17 46.15
1295-1313 10 26.77 10.06 28.49
1320-1366 8.24 135.64 8.32 136.05
1320-1313 12.37 128.3 12.42 128.66
1366-1313 5.77 34.38 5.82 35.2
Table 4. Distances and dihedral angles between the tryptophan chromophores in the MD-averaged structures of the free ALK
and ALK-Staurosporine complex. The distances are measured between the CD2 atoms from two residues and the dihedral
angles between the CD1 and CD3 atoms from the first residue and the CD3 and CD1 atoms from the second residue. The
atom names are according PDB nomenclature.
TRP Residues ALK Distance ALK Dihedral angle ALK-STU Distance ALK-STU Dihedral angle
(MD-averaged) (MD-averaged) (MD-averaged) (MD-averaged)
1295-1320 9.75 47.25 10.52 −115.01
1295-1366 11.44 59.44 11.26 −136.61
1295-1313 11.63 5.28 8.86 100.16
1320-1366 7.78 −31.41 7.75 62.06
1320-1313 12.46 118.05 11.87 110.7
1366-1313 5.72 18.48 5.85 15.66
This might be due to the fact that the crystal struc-
tures sometimes do not correspond to local minima
of the free molecule and, therefore, contain some re-
straints due to the crystal packing [39]. In the quantum-
chemically optimized structures an intramolecular hy-
drogen bond between the amino hydrogen and the
methoxy oxygen atoms of the sugar is formed as can
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Fig. 3 (colour online). The RMSD and RMSF values of STU.
be seen by the values for the corresponding distances
and angles in Table 1. Such hydrogen bonding interac-
tions might contribute to the binding of STU to kinase
molecules.
The correlation between the chemical nomenclature
and atom names according PDB is presented in Ta-
ble 2.
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Fig. 4 (colour online). Calculated ECD spectrum of STU at the B3LYP/6-31+G(d) level. The calculated rotational strengths
are presented as vertical bars.
Valuable insight into the interactions between STU
and kinases can be received by computational mod-
elling and in particular by using classical molecular
dynamics simulations which utilize sets of parameters
(force fields) for the bonding and the non-bonding in-
teraction and charges for the atoms in a molecule. In
order to explore the importance of the conformational
flexibility of STU we performed 10 ns MD simulations
in a solvent box of SPC water molecules. The geomet-
ric parameters of the averaged structure from the MD
simulations are also given in Table 1 and the root mean
square deviation (RMSD) and the root mean square
fluctuation (RMSF) profiles are shown in Figure 3.
These values suggest that the different parts of the
molecule exhibit different flexibilities and this would
have an impact on how STU interacts, accommodates,
and adapts within the kinases binding sites.
ECD is routinely applied for determining the abso-
lute configurations of small chiral compounds and of-
ten it is the only method of choice (when crystallog-
raphy and nuclear magnetic resonance are not appli-
cable) [40]. In protein science ECD is used to detect
changes in the secondary structure (far UV) and in the
tertiary structure (near UV) [14, 41, 42]. The near-UV
ECD can indicate delicate structural changes induced
by ligand binding, effects of mutation and catalysis.
The binding of STU to proteins can be investigated by
experimental ECD in combination with calculations.
If the ECD calculations based on modelled structures
are in good agreement with the experimental spectra
they can be used for evaluation of the structures of the
kinase-STU complexes as it has been demonstrated for
other proteins [19]. An important step for this process
is the calculation of the ECD spectrum of the free STU
using a relatively accurate method e. g. TD-DFT. The
predicted spectrum at B3LYP/6-31+G(d) level is pre-
sented in Figure 4. The spectrum is characterized by
two minima around 230 nm and 275 nm and two max-
ima at 250 nm and 310 nm. To the best of our knowl-
edge there is only one available experimental ECD
spectrum of STU in the literature [43] but it does not
contain the complete set of data, allowing quantita-
tive comparison, therefore we will make only a quali-
tative comparison. The experimental spectrum is char-
acterized by maxima at around 205 nm, 230 nm, and
300 nm and minima at around 210 nm and smaller one
around 265 nm [43]. Besides a red shift the calculated
ECD spectrum is in qualitative agreement with its ex-
perimental counterpart but further improvement can
possibly be achieved using an improved computational
model and trying alternative initial structures e. g. opti-
mized at higher quantenmechanical level and/or taken
from MD trajectory.
The binding of STU to kinases would affect their
ECD spectra in comparison with the free apoenzyme’s
spectra. This effect can be a result from two contribu-
tions:
i) the steric influence due to the changes in protein
conformation and in the orientation between protein
chromophores upon STU binding and
ii) the effect of the internal ECD of STU and its elec-
trostatic interactions with the protein chromophores
(aromatic and peptide ones).
Here we provide qualitative estimation of the first
effect using as a model for the complex between STU
and ALK, an enzyme of great biomedical and pharma-
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ceutical interest [21]. The second one requires more
extensive development and non-trivial validations of
models and calculations and is an object of an ongoing
project. The ECD spectra of the free enzyme and the
protein part of the ALK-STU complex were calculated
using
i) the respective crystal structures of the free en-
zyme, and protein parts of ALK-ADP and ALK-STU
complexes and
ii) the averaged structures from MD simulations
of the free enzyme and the both enzyme-ligand com-
plexes.
The averaged MD structures would allow for some
evaluation of the effects of the conformational re-
laxation and flexibility. In both cases the binding of
STU and ADP (as structural effect defined above) in-
fluences the ECD spectra (Fig. 5). There are, how-
ever, important differences. When the crystal struc-
tures are used, the calculated ECD spectrum of the
ALK-STU complex is much closer to the ECD spec-
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Fig. 5. Calculated near-UV ECD spectra of the free ALK and upon binding of STU and ADP: (a) calculated using the crystal
structures; (b) using the averaged structures from MD simulations; (c) the differential spectra for STU calculated from the
crystal structures and the MD-averaged structures.
trum of the free enzyme structure (Fig. 5a). When
the conformational flexibility is evaluated in MD sim-
ulations, the predicted CD spectrum of the ALK-
STU is much more different from the one of the
free enzyme and more similar to the one of ALK-
ADP (Fig. 5b). The differential spectra of the ALK-
STU complex show a much stronger impact of STU
binding when the conformational flexibility and relax-
ation is accounted for (Fig. 5c). A qualitative expla-
nation of this difference could be provided by look-
ing into the mutual orientation between the chro-
mophores in the crystal structures (Table 3) and MD-
averaged structures (Table 4) of ALK and ALK-STU
complexes. Certainly, this is only a qualitative result,
because the experimental ECD spectra of the free
ALK and ALK-STU complexes are not yet available,
but it is an important step towards a more compre-
hensive study involving better validation of structural
models, monopoles, and experimental ECD measure-
ments.
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The results presented here suggest that it would be
important to investigate more systematically the flex-
ibility of the free STU in solution and in enzyme-
ligand complexes. The ECD spectrum of the free STU
currently calculated semi-quantitatively could be im-
proved exploring more choices for the initial structure,
improving the computational model, and correlating to
a more extensive set of experimental data. A combina-
tion of experimental ECD spectroscopy and computa-
tional modelling would provide sensitive insight into
the mechanism of binding of STU to ALK and thus
would be useful for drug design.
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